TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $284,332 | -96.8% | 34,011 | -85.3% | 0.00% | -100.0% |
Q2 2021 | $8,972,000 | +50.3% | 231,293 | +86.7% | 0.01% | +40.0% |
Q1 2021 | $5,971,000 | -7.4% | 123,893 | 0.0% | 0.01% | -9.1% |
Q4 2020 | $6,445,000 | +155.6% | 123,893 | +31.5% | 0.01% | +120.0% |
Q3 2020 | $2,522,000 | +131.4% | 94,246 | +13.7% | 0.01% | +400.0% |
Q2 2018 | $1,090,000 | -17.0% | 82,888 | -10.4% | 0.00% | -66.7% |
Q1 2018 | $1,314,000 | – | 92,543 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
Parkwood LLC | 165,414 | $6,081 | 0.66% |
Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |